Interesting the cash flow slide on slide 19 of the presentation. Shows there was free cash flow available to pay dividends to shareholders. Similar analysis of DSH shows this was never the case for them.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%